Pharmaceuticals & Life Sciences · Preclinical Development

Formulation Development & CMC

Enhances→Stable

1–3 Years

1–3 years. Pilots and early adopters exist. Enterprise adoption accelerating but not mainstream.

Trajectories describe the observable direction of human effort — not a prediction about specific roles, headcount, or individual careers.

What You Do Today

Develop the drug product formulation — selecting excipients, optimizing dissolution and bioavailability, scaling from lab to pilot to commercial manufacturing. Characterize the API (active pharmaceutical ingredient), establish specifications, and build the CMC section of regulatory filings.

AI Technologies

Formulation Optimization AIProcess Analytical TechnologyCrystal Form PredictionDissolution Modeling

Roles Involved

Who works on this

Digital Transformation LeaderInnovation LeadResearch ScientistFormulation ScientistTechnical WriterProject Manager

VP/SVPDirectorIndividual ContributorCross-Functional

How It Works

ML models predict optimal formulation compositions based on API properties and target release profiles, reducing the number of experimental iterations. AI-driven process analytical technology monitors manufacturing parameters in real-time and adjusts processes to maintain product quality.

What Changes

Formulation development cycles compress as AI narrows the design space before lab work begins. Process understanding improves through continuous real-time monitoring rather than end-of-batch testing.

What Stays the Same

Scale-up challenges — what works at bench scale may not at commercial scale — and the regulatory strategy for CMC filings require deep formulation science and regulatory experience.

Cross-Industry Concepts

process optimization quality by design manufacturing science

Evidence & Sources

•FDA Pharmaceutical Quality for the 21st Century initiative
•ICH Q8/Q9/Q10 guidelines

Sources listed are directional references, not formal citations. Verify against primary sources before using in business cases or presentations.

Last reviewed: March 2026

What To Do Next

This section won't tell you what your numbers should be. It will show you how to find them yourself. Every instruction below produces a real, verifiable result in your organization. No benchmarks, no projections — just the steps to build your own evidence.

Establish Your Baseline

Know where you are before you move

Before adopting AI tools for formulation development & cmc, document your current state in preclinical development.

•

Map your current process: Document how formulation development & cmc works today — who does what, how long each step takes, and where the bottlenecks are. Use your EHR system data to establish a factual baseline.

•

Identify the judgment calls: Scale-up challenges — what works at bench scale may not at commercial scale — and the regulatory strategy for CMC filings require deep formulation science and regulatory experience. — these are the boundaries AI won't cross. Know them before you start.

•

Check your data readiness: AI tools for preclinical development need clean, accessible data. Check whether your EHR system has the historical data, integrations, and quality to support Formulation Optimization AI tools.

Without a baseline, you can't tell whether AI actually improved formulation development & cmc or just changed who does it.

Define Your Measures

What to track and how to calculate it

patient outcomes

How to calculate

Measure patient outcomes for formulation development & cmc before and after AI adoption. Pull from your EHR system.

Why it matters

This is the most direct indicator of whether AI is adding value to preclinical development.

clinical documentation quality

How to calculate

Track clinical documentation quality using the same methodology you use today. Don't change how you measure just because you changed how you work.

Why it matters

Speed without quality is just faster mistakes. Measure both together.

When to check: Check after 30 days of consistent use, then quarterly.

The commitment: Give new tools at least 30 days before judging. The first week is always awkward.

What NOT to measure: Don't measure AI adoption rate as a goal. Measure outcomes. If the tool helps with formulation development & cmc, people will use it.